Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct;27(5):187-196.
doi: 10.1089/hgtb.2016.044. Epub 2016 Sep 7.

A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products

Larissa H Haut  1 , Amanda L Gill  1   2 , Raj K Kurupati  1 , Ang Bian  1 , Yan Li  1 , Wynetta Giles-Davis  1 , Zhiquan Xiang  1 , Xiang Yang Zhou  1 , Hildegund C J Ertl  1
Affiliations

A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products

Larissa H Haut et al. Hum Gene Ther Methods. 2016 Oct.

Erratum in

Abstract

Adenovirus (Ad) is used extensively for construction of viral vectors, most commonly with deletion in its E1 and/or E3 genomic regions. Previously, our attempts to insert envelope proteins (Env) of HIV-1 into such vectors based on chimpanzee-derived Ad (AdC) viruses were thwarted. Here, we describe that genetic instability of an E1- and E3-deleted AdC vector of serotype C6 expressing Env of HIV-1 can be overcome by reinsertion of E3 sequences with anti-apoptotic activities. This partial E3 deletion presumably delays premature death of HEK-293 packaging cell lines due to Env-induced cell apoptosis. The same partial E3 deletion also allows for the generation of stable glycoprotein 140 (gp140)- and gp160-expressing Ad vectors based on AdC7, a distinct AdC serotype. Env-expressing AdC vectors containing the partial E3 deletion are genetically stable upon serial cell culture passaging, produce yields comparable to those of other AdC vectors, and induce transgene product-specific antibody responses in mice. A partial E3 deletion thereby allows expansion of the repertoire of transgenes that can be expressed by Ad vectors.

Keywords: HIV-1; genetic stability; immune responses; vaccine.

PubMed Disclaimer

Conflict of interest statement

Author Disclosure No competing financial interests exist.

Figures

<b>Figure 1.</b>
Figure 1.
Partially E3-deleted adenovirus C (AdC) vectors are genetically stable and express the transgene product in transfected HEK-293 cells. (A) indicates the deletions. (B) shows the results of the restriction enzyme digest of the viral DNA isolated after an early (5th) or late (12th) passage. The molecular weight ladder (MW) is shown on the right of each gel. (C) shows vector vields for partially-(gp140) or E3-deleted (gag) AdC vectors. (D) shows Western blots for the AdC-Env vectors conducted with lysates of infected HEK-293 cells. Color images available online at www.liebertpub.com/hgtb
<b>Figure 2.</b>
Figure 2.
AdC6-induced envelope protein (Env)–specific antibody responses. Groups of 5 mice were immunized with the vectors at the indicated doses and antibodies to the transgene product were measured in individual serially diluted sera harvested at baseline or 2, 4, or 8 weeks after immunization. Mice that received the 1010 virus particle (vp) dose were boosted with AdC7 vectors expressing the same transgene used for priming and sera were tested at 8 weeks after the boost (8wks pb). The graphs show adsorbance values as means with standard error of the mean (SEM) for serially diluted sera. The lines next to the legends show significant differences between the indicated groups by ANOVA. The statistical analyses were performed on area under the curve for each serum. –p > 0.05; *0.05 ≥ p > 0.01; **0.015 ≥ p > 0.001; ***0.001 ≥ p > 0.0001; ****p ≤ 0.00001.
<b>Figure 3.</b>
Figure 3.
AdC7-induced Env-specific antibody responses. The graphs show results for sera from AdC7-immunized mice (as described for AdC6 in Fig. 2).
<b>Figure 4.</b>
Figure 4.
Isotypes of vaccine-induced antibodies to Env. Stacked columns show mean adsorbance + SEM of Env-specific antibodies in sera of mice harvested at baseline, 8 weeks post priming (8 wks pp) or 8 weeks post boosting (8 wks pb). Lines with -/* indicate significant differences between the indicated groups, as in Fig 2. From left to right -/* are organized following the top-to-bottom list of the isotypes listed in the right lower corner of the graph.
<b>Figure 5.</b>
Figure 5.
AdC-induced antibodies to the V2 loop. The graphs show adsorbance values as means with SEM for serially diluted sera from the same mice shown in Figs. 2 and 3. Sera harvested at baseline, at 8 weeks after priming, or at 8 weeks after the boost were tested. Lines with -/* show significant differences between the indicated groups again comparing area under the curve of individual sera.
<b>Fig 6.</b>
Fig 6.
Affinity of AdC-induced antibodies. The graphs show the results of a NH4SCN replacement assay conducted with a 1:200 dilution of sera from individual mice that had been immunized 8 weeks previously. Data are shown as percent adsorption in the presence of various concentrations of NH4SCN compared with adsorption without NH4SCN. The statistical analysis compared results at the same NH4SCN concentrations between the two groups in each graph by multiple t-tests with Holms-Sidak correction. Symbols are as in Fig. 2.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Benihoud K, Yeh P, Perricaudet M. Adenovirus vectors for gene delivery. Curr Opin Biotechnol 1999;10:440–447 - PubMed
    1. Appaiahgari MB, Vrati S. Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls. Expert Opin Biol Ther 2015;15:337–351 - PubMed
    1. Muruve DA. The innate immune response to adenovirus vectors. Hum Gene Ther 2004;15:1157–66 - PubMed
    1. Hensley SE, Giles-Davis W, McCoy KC, et al. . Dendritic cell maturation, but not CD8+ T cell induction, is dependent on type I IFN signaling during vaccination with adenovirus vectors. J Immunol 2005;175:6032–6041 - PubMed
    1. Tatsis N, Ertl HC. Adenoviruses as vaccine vectors. Mol Ther 2004;10:616–629 - PMC - PubMed

Publication types

Substances